CATHERINE M VACZY Insider Trading
Get free email notifications about insider trading for CATHERINE M VACZY.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of CATHERINE M VACZY. CATHERINE M VACZY is a EVP and General Counsel in Caladrius Biosciences, Inc. ($NBS) and a Exe. V.P. & Gen. Counsel in Caladrius Biosciences, Inc. ($NBS) and a Exec VP & Gen Counsel in Caladrius Biosciences, Inc. ($NBS) and a Exec. V.P. & General Counsel in Caladrius Biosciences, Inc. ($NBS) and a Exec. V.P. and General Counsel in Caladrius Biosciences, Inc. ($NBS) and an Executive V.P. & Genl. Counsel in Caladrius Biosciences, Inc. ($NBS) and an Executive VP and Gen. Counsel in Caladrius Biosciences, Inc. ($NBS) and a General Counsel in Caladrius Biosciences, Inc. ($NBS) and a EVP GC Chief Strategy Officer in Genprex, Inc. ($GNPX).
Address: C/O PHASE III MEDICAL, INC. 330 SOUTH SERVICE ROAD, SUITE 120 MELVILLE 11747 NY
Companies in which CATHERINE M VACZY is an Insider
CALADRIUS BIOSCIENCES, INC.
Industry: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
Position of CATHERINE M VACZY: Exec. V.P. and General Counsel, EVP and General Counsel, Exec. V.P. & General Counsel, Executive VP and Gen. Counsel, Executive V.P. & Genl. Counsel, Exe. V.P. & Gen. Counsel, Exec VP & Gen Counsel
Holdings: 71,234 shares
Latest Transaction: Apr 14 2015
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Genprex, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of CATHERINE M VACZY: EVP GC Chief Strategy Officer
Holdings: 0 shares
Latest Transaction: Mar 23 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of CATHERINE M VACZY
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 23 2021 | GNPX | Genprex, Inc. | VACZY CATHERINE M | EVP GC Chief Strate ... | Option Exercise | A | 5.08 | 200,000 | 1,016,000 | 200,000 | |
| Mar 23 2021 | GNPX | Genprex, Inc. | VACZY CATHERINE M | EVP GC Chief Strate ... | Option Exercise | A | 5.08 | 200,000 | 1,016,000 | 200,000 | |
| Apr 14 2015 | NBS | Caladrius Bioscien ... | VACZY CATHERINE M | General Counsel | Grant | A | 0.00 | 3,971 | 0 | 71,234 | 67.3 K to 71.2 K (+5.90 %) |
| Jun 23 2006 | NBS | Caladrius Bioscien ... | VACZY CATHERINE M | Exec. V.P. and Gene ... | Grant | A | 0.00 | 20,274 | 0 | 6,336,465 | 6.3 M to 6.3 M (+0.32 %) |
| Jun 06 2006 | NBS | Caladrius Bioscien ... | VACZY CATHERINE M | Exec. V.P. & Genera ... | Option Exercise | A | 0.05 | 1,000,000 | 53,000 | 1,000,000 | |
| Jun 06 2006 | NBS | Caladrius Bioscien ... | VACZY CATHERINE M | Exec. V.P. & Genera ... | Grant | A | 0.00 | 609,703 | 0 | 6,316,191 | 5.7 M to 6.3 M (+10.68 %) |
| Dec 23 2005 | NBS | Caladrius Bioscien ... | VACZY CATHERINE M | EVP and General Cou ... | Option Exercise | A | 0.06 | 200,000 | 12,000 | 200,000 |